- Home
- PROK vs JFB Comparison
PROK vs JFB Comparison
Compare PROK & JFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- JFB
- Stock Information
- Founded
- PROK 2015
- JFB 2014
- Country
- PROK United States
- JFB United States
- Employees
- PROK N/A
- JFB N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- JFB
- Sector
- PROK Health Care
- JFB
- Exchange
- PROK Nasdaq
- JFB NYSE
- Market Cap
- PROK 85.5M
- JFB 68.6M
- IPO Year
- PROK N/A
- JFB 2025
- Fundamental
- Price
- PROK $3.27
- JFB $6.79
- Analyst Decision
- PROK Buy
- JFB
- Analyst Count
- PROK 5
- JFB 0
- Target Price
- PROK $6.25
- JFB N/A
- AVG Volume (30 Days)
- PROK 37.1M
- JFB 47.3K
- Earning Date
- PROK 08-08-2025
- JFB 08-11-2025
- Dividend Yield
- PROK N/A
- JFB N/A
- EPS Growth
- PROK N/A
- JFB N/A
- EPS
- PROK N/A
- JFB 0.00
- Revenue
- PROK $306,000.00
- JFB $25,946,544.00
- Revenue This Year
- PROK $85.21
- JFB N/A
- Revenue Next Year
- PROK N/A
- JFB N/A
- P/E Ratio
- PROK N/A
- JFB $1,681.72
- Revenue Growth
- PROK N/A
- JFB N/A
- 52 Week Low
- PROK $0.46
- JFB $3.39
- 52 Week High
- PROK $7.13
- JFB $10.46
- Technical
- Relative Strength Index (RSI)
- PROK 62.08
- JFB N/A
- Support Level
- PROK $3.17
- JFB N/A
- Resistance Level
- PROK $4.05
- JFB N/A
- Average True Range (ATR)
- PROK 1.00
- JFB 0.00
- MACD
- PROK 0.13
- JFB 0.00
- Stochastic Oscillator
- PROK 43.10
- JFB 0.00
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About JFB JFB CONSTRUCTION HOLDINGS
JFB Construction Holdings is a commercial and residential real estate construction and development company. It is engaged in retail corporate buildouts, multifamily community developments and luxury residential homes, with a focus on fostering long-term relationships with clients, partners, and communities. The company operates in three distinct business segments: Commercial Construction, Residential Construction, and Real Estate Development. Key revenue is generated from Commercial Construction: This segment includes all activities related to the construction of commercial properties such as office buildings, retail spaces, and industrial facilities.